SOLVSolventum
$87.38+17% 1Y
$87.38
$62.4952 weeks$92.40
SOLV in its own filings
Nothing in SOLV's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
58
Events found in the filings · across 261 filings · the record starts in 2023
- Hard flags
- none
Hard flags
- Most recent filing
- Aug 5, 2026
Most recent filing · Form 10-Q
- Record starts
- Mar 15, 2023
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 5, 2026
- SEC comment-letter activity14 occurrences
- 2024-11-26
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 5, 2026Solventum Reports Second Quarter 2026 Financial Results.Earnings release · press release
- Aug 5, 2026The information furnished pursuant to this.Regulation FD disclosure · Form 8-K
- Jul 20, 2026On July 16, 2026, the Board of Directors of Solventum Corporation (the “Company”) appointed Neil Zieselman to serve as Senior Vice President, Controller and Chief Accounting Officer of the Company, effective as of August 10, 2026.Director or officer change · Form 8-K
- Jun 5, 2026On May 10, 2024, Plaintiff Eric Gilbert (the “Plaintiff”), on behalf of a putative class of stockholders of Solventum Corporation (the “Company”), filed a Verified Class Action Complaint (the “Action”) in the Court of Chancery of the State of Delaware (the “Delaware Court”), challenging the validity of certain aspects …Other event · Form 8-K
- May 27, 2026On May 21, 2026, the Talent Committee (the “Committee”) of the Board of Directors of Solventum Corporation (the “Company”) adopted and approved the Solventum Executive Severance Plan and Summary Plan Description (the “Severance Plan”), effective June 1, 2026.Director or officer change · Form 8-K
- May 5, 2026Solventum Reports First Quarter 2026 Financial Results.Earnings release · press release
- Mar 24, 2026On March 20, 2026, Mary Wilcox informed Solventum Corporation (the “Company”) of her intent to retire and resign from her position as Chief Accounting Officer of the Company following a search for and appointment of her successor.Director or officer change · Form 8-K
- Feb 26, 2026Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance.Earnings release · press release
- Nov 6, 2025Solventum Reports Third Quarter 2025 Financial Results.Earnings release · press release
- Oct 21, 2025On October 21, 2025, Solventum Corporation (the “Company”) announced that Heather Knight has been appointed to serve in the newly created role of Chief Commercial Officer of the Company, effective as of November 10, 2025.Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Medical Instruments & Supplies
The closest names by size in the same industry